Vascular Endothelial Growth Factor Polymorphisms in Mantle Cell Lymphoma

被引:16
作者
Galimberti, S. [1 ]
Nagy, B. [7 ]
Palumbo, G. A. [4 ]
Ciancia, E. [3 ]
Buda, G. [1 ]
Orciuolo, E. [1 ]
Melosi, A. [5 ]
Lambelet, P. [6 ]
Ronca, F. [2 ]
Petrini, M. [1 ]
机构
[1] Univ Pisa, Dept Oncol Transplant & New Adv Med, Hematol Sect, IT-56126 Pisa, Italy
[2] Univ Pisa, Dept Biochem, IT-56126 Pisa, Italy
[3] Univ Pisana, Azienda Osped, Pathol Sect, Pisa, Italy
[4] Univ Catania, Dept Biomed Sci, Div Hematol, Osped Ferrarotto, Catania, Italy
[5] UO Oncol, Azienda Osped Lucca, Pietrasanta, Lucca, Italy
[6] UO Internal Med, Osped Un Versilia, Pietrasanta, Lucca, Italy
[7] Semmelweis Univ, Genet Lab, H-1085 Budapest, Hungary
关键词
Mantle cell lymphoma; Polymorphism; Single nucleotide polymorphism; Vascular endothelial growth factor; NON-HODGKINS-LYMPHOMA; FACTOR GENE; VEGF EXPRESSION; CANCER; TIME; ANGIOGENESIS; RITUXIMAB; PROMOTER; TRIAL;
D O I
10.1159/000267826
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
In this study, we determined the allele and genotype frequencies of vascular endothelial growth factor (VEGF) G+405C, C-460T, C+936T and C-2578A single nucleotide polymorphisms (SNPs) in 32 patients affected by mantle cell lymphoma (MCL) and 58 healthy controls. Real-time PCR combined with melting curve analysis was used for the determination of SNP alleles. A significant difference in the allele frequency of VEGF C-460T and C+936T SNPs in MCL and healthy cases was not observed. On the contrary, VEGF G+405C and C-2578A SNP allele distribution was significantly lower in the patient group than among normal controls (p = 0.014, p = 0.001). This observation suggests that further investigation is warranted, both in vitro and in a larger series of patients, to further examine the role of VEGF polymorphisms in the pathogenesis of MCL. In addition, the use of quantitative real-time PCR combined with a melting curve analysis method in the detection of the 4 VEGF SNPs may have the potential to replace older and more time-consuming PCR-RFLP methods and bears further investigation. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:91 / 95
页数:5
相关论文
共 27 条
[1]
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes [J].
Aguayo, A ;
Kantarjian, H ;
Manshouri, T ;
Gidel, C ;
Estey, E ;
Thomas, D ;
Koller, C ;
Estrov, Z ;
O'Brien, S ;
Keating, M ;
Freireich, E ;
Albitar, M .
BLOOD, 2000, 96 (06) :2240-2245
[2]
Aguayo Alvaro, 2004, Curr Hematol Rep, V3, P184
[3]
Gastric Cancer Risk Predisposition and Prognostic Significance of Vascular Endothelial Growth Factor (VEGF) Gene Polymorphisms-A Case-Control Study in an Omani Population [J].
Al-Moundhri, Mansour S. ;
Al-Nabhani, Maryam ;
Burney, Ikram A. ;
Al-Farsi, Abdul-Aziz ;
Al-Bahrani, Bassim .
MOLECULAR CARCINOGENESIS, 2009, 48 (12) :1170-1176
[4]
The positive correlation between gene expression of the two angiogenic factors: VEGF and BMP-2 in lung cancer patients [J].
Bieniasz, Magdalena ;
Oszajca, Katarzyna ;
Eusebio, Mak ;
Kordiak, Jacek ;
Bartkowiak, Jacek ;
Szemraj, Janusz .
LUNG CANCER, 2009, 66 (03) :319-326
[5]
Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene [J].
Brogan, IJ ;
Khan, N ;
Isaac, K ;
Hutchinson, JA ;
Pravica, V ;
Hutchinson, IV .
HUMAN IMMUNOLOGY, 1999, 60 (12) :1245-1249
[6]
DEBONT ES, 2000, CLIN CANCER RES, V8, P2856
[7]
The biology of VEGF and its receptors [J].
Ferrara, N ;
Gerber, HP ;
LeCouter, J .
NATURE MEDICINE, 2003, 9 (06) :669-676
[8]
Influence of the VEGF-A 936C>T germinal polymorphism on tumoral VEGF expression in head and neck cancer [J].
Formento, Jean-Louis ;
Etienne-Grimaldi, Marie-Christine ;
Francoual, Mireille ;
Pages, Gilles ;
Onesto, Cercina ;
Formento, Patricia ;
Chamorey, Emmanuel ;
Dassonville, Olivier ;
Poissonnet, Gilles ;
Milano, Gerard .
PHARMACOGENOMICS, 2009, 10 (08) :1277-1283
[9]
Human endometrial angiogenesis [J].
Gargett, CE ;
Rogers, PAW .
REPRODUCTION, 2001, 121 (02) :181-186
[10]
Prognostic significance of microvessel density and vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma [J].
Hazar, B ;
Paydas, S ;
Zorludemir, S ;
Sahin, B ;
Tuncer, I .
LEUKEMIA & LYMPHOMA, 2003, 44 (12) :2089-2093